Incorporating a Pharmacist into the Discharge Process: A Unit-Based Transitions of Care Pilot

Readmissions reduction program. Centers for Medicare & Medicaid Services. www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. Accessed May 18, 2015.

National Transitions of Care Coalition. www.ntocc.org. Accessed May 18, 2015.

Kripalani S. , Roumie C.L. , Dalal A.K. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: A randomized trial. Ann Intern Med. 2012; 157(1): 1–10.

Teymoorian S.S. , Dutcher D. , Woods M. Association between postdischarge adverse drug reactions and 30-day hospital readmission in patients aged 80 and older. J Am Geriatr Soc. 2011; 59(5): 948–949.

Pal A. , Babbott S. , Wilkinson S.T. Can the targeted use of a discharge pharmacist significantly decrease 30-day readmissions? Hosp Pharm. 2013; 48(5): 380–388.

Wimmer B.C. , Dent E. , Bell J.S. Medication regimen complexity and unplanned hospital readmissions in older people. Ann Pharmacother. 2014; 48(9): 1120–1128.

Pavon J.M. , Zhao Y.F. , McConnell E. Identifying risk of readmission in hospitalized elderly adults through inpatient medication exposure. J Am Geriatr Soc. 2014; 62(6): 1116–1121.

Bates D.W. , Cullen D.J. , Laird N. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995; 274(1): 29–34.

Kwan J.L. , Lo L. , Sampson M. Medication reconciliation during transitions of care as a patient safety strategy: A systematic review. Ann Intern Med. 2013; 158(5 Pt 2): 397–403.

Wong J.D. , Bajcar J.M. , Wong G.G. Medication reconciliation at hospital discharge: Evaluating discrepancies. Ann Pharmacother. 2008; 42(10): 1373–1379.

Eisenhower C. Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD. Ann Pharmacother. 2014; 48(2): 203–208.

The Joint Commission. National patient safety goals effective January 1, 2014. Hospital Accreditation Program. http://www.jointcommission.org/assets/1/6/HAP_NPSG_Chapter_2014.pdf. Accessed May 21, 2015.

Sen S. , Bowen J.F. , Ganetsky V.S. Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings. Pharm Pract. 2014; 12(2): 1–8.

Schnipper J.L. , Kirwin J.L. , Cotugno M.C. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006; 166(5): 565–571.

Koehler B.E. , Richter K.M. , Youngblood L. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009; 4(4): 211–218.

Predixion (Predictive Analytics Solutions). http://www.predixionsoftware.com. Accessed May 21, 2015.

Christy S. , Sin B. , Gim S. Impact of an integrated pharmacy transitions of care pilot program in an urban hospital [published online ahead of print March 2015]. J Pharm Pract.

Rubin D.J. Hospital readmission of patients with diabetes. Curr Diab Rep. 2015; 15(4): 17.

Still K.L. , Davis A.K. , Chilipko A.A. Evaluation of a pharmacy-driven inpatient discharge counseling services: Impact on 30-day readmission rates. Consult Pharm. 2013; 28(12): 775–785.

Sehgal V. , Bajwa S.J. , Sehgal R. Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital. J Family Med Prim Care. 2013; 2(2): 194–199.

Rohrer J.E. , Garrison G. , Oberhelman S.A. Epidemiology of polypharmacy among family medicine patients at hospital discharge. J Prim Care Community Health. 2013; 4(2): 101–105.

Walker P.C. , Bernstein S.J. , Tucker Jones J.N. Impact of a pharmacist-facilitated hospital discharge program: A quasi-experimental study. Arch Intern Med. 2009; 169(21): 2003–2010.